BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2150570)

  • 1. Etodolac: efficacy in osteoarthritis and effects on chondrocyte function.
    Bacon PA
    Rheumatol Int; 1990; 10 Suppl():3-7. PubMed ID: 2150570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etodolac preserves cartilage-specific phenotype in human chondrocytes: effects on type II collagen synthesis and associated mRNA levels.
    Goldring MB; Sohbat E; Elwell JM; Chang JY
    Eur J Rheumatol Inflamm; 1990; 10(1):10-21. PubMed ID: 2146129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of etodolac on human chondrocytes cultivated in three dimensional culture.
    Henrotin Y; Bassleer C; Reginster JY; Franchimont P
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():36-42. PubMed ID: 2545406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.
    Watson M; Brookes ST; Faulkner A; Kirwan J
    Cochrane Database Syst Rev; 2007 Jul; 2006(1):CD000142. PubMed ID: 17636601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee.
    Platt PN
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():54-62. PubMed ID: 2525984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of Etodolac and acetylsalicylic acid on human chondrocyte metabolism.
    Henrotin Y; Bassleer C; Franchimont P
    Agents Actions; 1992 Jul; 36(3-4):317-23. PubMed ID: 1388320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee.
    Watson MC; Brookes ST; Kirwan JR; Faulkner A
    Cochrane Database Syst Rev; 2000; (2):CD000142. PubMed ID: 10796306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the antiarthritic efficacy and safety of etodolac.
    Zvaifler N
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():43-53. PubMed ID: 2525982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.
    Lanza FL; Arnold JD
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():5-15. PubMed ID: 2525983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. I: Collagen synthesis.
    Mauviel A; Redini F; Loyau G; Pujol JP
    Agents Actions; 1990 Nov; 31(3-4):345-52. PubMed ID: 2150740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee.
    Porzio F
    Rheumatol Int; 1993; 13(2 Suppl):S19-24. PubMed ID: 8210920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale open trials with etodolac (Lodine) in France: an assessment of safety.
    Benhamou CL
    Rheumatol Int; 1990; 10 Suppl():29-34. PubMed ID: 2150569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global safety of etodolac: reports from worldwide postmarketing surveillance studies.
    Serni U
    Rheumatol Int; 1990; 10 Suppl():23-7. PubMed ID: 2150568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of etodolac and piroxicam in the treatment of osteoarthritis.
    Freitas GG
    Curr Med Res Opin; 1990; 12(4):255-62. PubMed ID: 2150187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis.
    Veys EM
    Eur J Rheumatol Inflamm; 1994; 14(1):23-7. PubMed ID: 7744125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins.
    Russell RI
    Rheumatol Int; 1990; 10 Suppl():17-21. PubMed ID: 2150567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
    Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
    Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee.
    Astorga Paulsen G; Baigun S; Galvao de Figueiredo J; Gomes de Freitas G
    Curr Med Res Opin; 1991; 12(6):401-12. PubMed ID: 1828415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation.
    Inoue K; Motonaga A; Dainaka J; Nishimura T; Hashii H; Yamate K; Ueda F; Kimura K
    Prostaglandins Leukot Essent Fatty Acids; 1994 Dec; 51(6):457-62. PubMed ID: 7708812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.